Abstract
Viral infection in animals and plants is a serious problem worldwide. It causes dramatic losses in health and economy. Many approaches to combat with viral infectious diseases have been intensively investigated. Measures taken against viral infections can either aim for protecting from viral infection or eliminating the viruses after infection. RNA dependent RNA polymerase (RdRp) is a key enzyme for viral replication and found in all positive strand RNA viruses. Disturbing the RdRp activity therefore results in reducing or inhibiting the virus infection. In this review we focus on reviewing different strategies and agents to inhibit the RdRps of different mammalian and plant positive-sense (ss) RNA viruses. The strategies described in this review are mainly focusing on interference of the nucleotides which are the substrates need for RdRp and blocking the RdRp itself by using chemical agents or antibodies specifically binding to the different domains of the RdRps. Moreover using small interfering (si) RNA technology platform to inhibit the RdRp activity is also discussed.
Current Enzyme Inhibition
Title: Inhibitions of Positive-Sense (ss) RNA Viruses RNA-Dependent RNA Polymerases
Volume: 5 Issue: 4
Author(s): Kajohn Boonrod and Gabriele Krczal
Affiliation:
Abstract: Viral infection in animals and plants is a serious problem worldwide. It causes dramatic losses in health and economy. Many approaches to combat with viral infectious diseases have been intensively investigated. Measures taken against viral infections can either aim for protecting from viral infection or eliminating the viruses after infection. RNA dependent RNA polymerase (RdRp) is a key enzyme for viral replication and found in all positive strand RNA viruses. Disturbing the RdRp activity therefore results in reducing or inhibiting the virus infection. In this review we focus on reviewing different strategies and agents to inhibit the RdRps of different mammalian and plant positive-sense (ss) RNA viruses. The strategies described in this review are mainly focusing on interference of the nucleotides which are the substrates need for RdRp and blocking the RdRp itself by using chemical agents or antibodies specifically binding to the different domains of the RdRps. Moreover using small interfering (si) RNA technology platform to inhibit the RdRp activity is also discussed.
Export Options
About this article
Cite this article as:
Boonrod Kajohn and Krczal Gabriele, Inhibitions of Positive-Sense (ss) RNA Viruses RNA-Dependent RNA Polymerases, Current Enzyme Inhibition 2009; 5 (4) . https://dx.doi.org/10.2174/157340809789630262
DOI https://dx.doi.org/10.2174/157340809789630262 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Crossed Cerebellar Diaschisis in Alzheimer’s Disease
Current Alzheimer Research Male Pelvic Pain: Beyond Urology and Chronic Prostatitis
Current Rheumatology Reviews Coumarins as Inhibitors of HIV Reverse Transcriptase
Current HIV Research Subject index to volume 1
Current HIV Research Link of COVID-19 and Neurodegenerative Disorders
CNS & Neurological Disorders - Drug Targets Astrocytes Exert and Control Immune Responses in the Brain
Current Immunology Reviews (Discontinued) HIV Vaccines: A Global Perspective
Current Molecular Medicine Childhood Infectious Encephalitis: An Overview of Clinical Features, Investigations, Treatment, and Recent Patents
Recent Patents on Inflammation & Allergy Drug Discovery Novel Therapeutic Strategies for Dementia
CNS & Neurological Disorders - Drug Targets Predicted SARS-CoV-2 miRNAs Associated with Epigenetic Viral Pathogenesis and the Detection of New Possible Drugs for Covid-19
Current Drug Delivery Borna Disease Virus (BDV): Neuropharmacological Effects of a CNS Viral Infection
Current Neuropharmacology Persons with Co-Existing Neurological Disorders: Risk Analysis, Considerations and Management in COVID-19 Pandemic
CNS & Neurological Disorders - Drug Targets Under the Microscope: Focus on Chlamydia pneumoniae Infection and Multiple Sclerosis
Current Neurovascular Research Neuroinflammation in Sepsis: Sepsis Associated Delirium
Cardiovascular & Hematological Disorders-Drug Targets Midkine: A Promising Molecule for Drug Development to Treat Diseases of the Central Nervous System
Current Pharmaceutical Design Challenges with Mosquito-borne Viral Diseases: Outbreak of the Monsters
Current Topics in Medicinal Chemistry Regenerative Medicine: Does Erythropoietin have a Role?
Current Pharmaceutical Design West Nile Virus NS2B/NS3 Protease As An Antiviral Target
Current Medicinal Chemistry Chronic Cerebrospinal Venous Insufficiency (CCSVI) and Multiple Sclerosis (MS): A Critical Review
CNS & Neurological Disorders - Drug Targets The Usefulness and Challenges of Transgenic Mouse Models in the Study of Alzheimers Disease
CNS & Neurological Disorders - Drug Targets